COCHLEAR LTD/ AU000000COH5 /
12/1/2023 8:01:43 AM | Chg. -0.5200 | Volume | Bid9:57:48 PM | Ask9:57:48 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
164.6400EUR | -0.31% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 10.32 bill.EUR | - | - |
Newsfile Corp
4/3
JIUYEE Announces the Launch of Its Revolutionary New Product - a Hearing Aid like Never Before
GlobeNewswire
3/25/2022
Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth Conference
GlobeNewswire
3/24/2022
Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for Pedma...
GlobeNewswire
3/21/2022
Osler Diagnostics Appoints Chris Smith as Chairman of the Board and David Berry as a Non-Executive D...
GlobeNewswire
3/11/2022
ENTA Conducting Clinical Trial of Investigational Regenerative Medication to Restore Hearing Functi...
GlobeNewswire
2/28/2022
Otonomy Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2/22/2022
Otonomy Completes Enrollment in Phase 2 Clinical Trial of OTO-313 in Tinnitus
GlobeNewswire
1/25/2022
Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meetin...
GlobeNewswire
1/21/2022
AudioSense Hearing, Balance & Concussion Celebrates Move to a New Exciting Location and Expanding Te...
GlobeNewswire
12/15/2021
Alfred E. Mann Foundation for Scientific Research Strengthens Executive Team with Two Key Appointmen...
GlobeNewswire
12/1/2021
VisiSonics Partners with University of Maryland to Pioneer 3D Audiogram Technology
GlobeNewswire
11/30/2021
Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application f...
GlobeNewswire
11/29/2021
Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug App...
GlobeNewswire
11/10/2021
Otonomy Reports Third Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
11/10/2021
Decibel Therapeutics Reports Third Quarter 2021 Financial Results and Corporate Update
GlobeNewswire
11/10/2021
Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business Update